CTLA4 and neoplasm: Tumor cells exploit these regulatory pathways by expressing immune checkpoint molecules and their corresponding ligands—B7 for cytotoxic T-lymphocyte-associated antigen 4 and programmed death-ligand 1 for programmed cell death protein 1—on their surface or on antigen-presenting cells.